Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Could Increase Access To Non-Pharmacological Pain Treatments, US Congress Report Says

Executive Summary

A majority of providers, payers, device companies and others with a stake in opioid treatment and substance use disorder surveyed by lawmakers told the US House Ways and Means Committee that public insurers such as Medicare need to increase access to non-pharmacological and non-opioid treatments for pain, according to a congressional whitepaper on opioids.

You may also be interested in...



Pay Reforms Proposed For Device Procedures At Surgical Centers

The US Medicare agency proposed a reform on July 25 that could expand certain device procedures at ambulatory surgical centers. It also says it wants comments on payment barriers to non-opioid device pain-management alternatives in its proposed 2019 outpatient and ambulatory surgical center payment rule.

Medtech Tools To Help Address Opioid Crisis Face Reimbursement Challenges

A wide variety of devices that could either serve as pain-relief substitutes for opioids, help manage opioid addictions or tackle distribution issues with the overly prescribed medications are facing reimbursement challenges at the US Centers for Medicare and Medicaid Services.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel